PL2598494T3 - Ulepszony sposób wytwarzania febuksostatu - Google Patents

Ulepszony sposób wytwarzania febuksostatu

Info

Publication number
PL2598494T3
PL2598494T3 PL11748746T PL11748746T PL2598494T3 PL 2598494 T3 PL2598494 T3 PL 2598494T3 PL 11748746 T PL11748746 T PL 11748746T PL 11748746 T PL11748746 T PL 11748746T PL 2598494 T3 PL2598494 T3 PL 2598494T3
Authority
PL
Poland
Prior art keywords
febuxostat
preparation
improved process
improved
Prior art date
Application number
PL11748746T
Other languages
English (en)
Inventor
Pranab Chatterjee
Asok Nath
Sarbjot Singh Sokhi
Mohan Prasad
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of PL2598494T3 publication Critical patent/PL2598494T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL11748746T 2010-07-30 2011-07-15 Ulepszony sposób wytwarzania febuksostatu PL2598494T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1805DE2010 2010-07-30
PCT/IB2011/053171 WO2012014117A1 (en) 2010-07-30 2011-07-15 Improved process for the preparation of febuxostat
EP11748746.2A EP2598494B1 (en) 2010-07-30 2011-07-15 Improved process for the preparation of febuxostat

Publications (1)

Publication Number Publication Date
PL2598494T3 true PL2598494T3 (pl) 2015-03-31

Family

ID=44511131

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11748746T PL2598494T3 (pl) 2010-07-30 2011-07-15 Ulepszony sposób wytwarzania febuksostatu

Country Status (7)

Country Link
US (1) US8916713B2 (pl)
EP (1) EP2598494B1 (pl)
AU (1) AU2011284400B2 (pl)
CA (1) CA2806695C (pl)
PL (1) PL2598494T3 (pl)
WO (1) WO2012014117A1 (pl)
ZA (1) ZA201300776B (pl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10682372B2 (en) 2015-08-26 2020-06-16 Stagen Co., Ltd. Intracellular ATP enhancer

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103788010B (zh) * 2012-11-01 2015-11-25 北大方正集团有限公司 非布索坦中间体及其制备方法
CN103012311A (zh) * 2012-12-06 2013-04-03 华润赛科药业有限责任公司 一种高纯度非布司他的制备方法
CN103333134B (zh) * 2013-03-01 2016-02-24 沈阳药科大学 2-(3-氰基-4-烷氧基)苯基-4-取代噻唑-5-甲酸类化合物、组合物及其制备方法和用途
CN104418823A (zh) * 2013-09-02 2015-03-18 上海龙翔生物医药开发有限公司 非布索坦中间体的制备方法
KR101630819B1 (ko) * 2014-09-26 2016-06-16 주식회사 메디켐코리아 페북소스타트의 제조 방법
CN108084112A (zh) * 2017-12-28 2018-05-29 北京沃邦医药科技有限公司 一种非布司他同分异构体的合成方法
CN110824067A (zh) * 2019-12-11 2020-02-21 天津药物研究院有限公司 一种非布司他中基因毒性杂质的检测方法
CN111039891A (zh) * 2019-12-26 2020-04-21 杭州朱养心药业有限公司 合成非布司他及其中间体的方法
CN111072591A (zh) * 2019-12-26 2020-04-28 杭州朱养心药业有限公司 非布司他和中间体及其合成

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03169735A (ja) 1989-11-30 1991-07-23 Nissan Motor Co Ltd 車両におけるロール剛性配分及び差動制限力の総合制御装置
JPH03202607A (ja) 1989-12-29 1991-09-04 Kubota Corp エンジンの排気浄化装置
ATE142494T1 (de) 1990-11-30 1996-09-15 Teijin Ltd 2-arylthiazolderivat sowie dieses enthaltendes arzneimittel
JP3169735B2 (ja) 1993-04-08 2001-05-28 帝人株式会社 （アルコキシシアノフェニル）チアゾール誘導体の製造方法
JP2706037B2 (ja) 1993-04-13 1998-01-28 帝人株式会社 シアノ化合物およびその製造方法
JP2834971B2 (ja) 1993-05-25 1998-12-14 帝人株式会社 ２−（４−アルコキシ−３−シアノフェニル）チアゾール誘導体の製造法およびその新規製造中間体
JP3202607B2 (ja) 1996-08-01 2001-08-27 帝人株式会社 ２−（４−アルコキシ−３−シアノフェニル）チアゾール誘導体の製造法
JPH10139770A (ja) 1996-11-08 1998-05-26 Teijin Ltd ２−（３−シアノフェニル）チアゾール誘導体の製造法
WO2011031409A1 (en) * 2009-09-10 2011-03-17 Teva Pharmaceutical Industries Ltd. Processes for preparing febuxostat
WO2011073617A1 (en) * 2009-12-14 2011-06-23 Cipla Limited Processes for the preparation of febuxostat and salts thereof
WO2011101867A2 (en) * 2010-02-19 2011-08-25 Cadila Healthcare Limited Substantially pure salts of febuxostat and processes for preparation thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10682372B2 (en) 2015-08-26 2020-06-16 Stagen Co., Ltd. Intracellular ATP enhancer
RU2728722C2 (ru) * 2015-08-26 2020-07-30 Стаджен Ко., Лтд. Усилитель внутриклеточного атф

Also Published As

Publication number Publication date
US20130245278A1 (en) 2013-09-19
EP2598494B1 (en) 2014-11-26
AU2011284400B2 (en) 2013-11-07
US8916713B2 (en) 2014-12-23
WO2012014117A1 (en) 2012-02-02
ZA201300776B (en) 2013-09-25
EP2598494A1 (en) 2013-06-05
CA2806695C (en) 2015-06-16
AU2011284400A1 (en) 2013-02-14
CA2806695A1 (en) 2012-02-02

Similar Documents

Publication Publication Date Title
EP2609120A4 (en) IMPROVED PROCESS FOR PREPARING SUGAMMADEX
ZA201206095B (en) Process for the preparation of isoxazoline derivatives
EP2552874A4 (en) PROCESS FOR PREPARING HEXAFLUOR-2 BUTENE
ZA201202504B (en) Process for the preparation of calcobutrol
IL220523A0 (en) New process for the preparation of dronedarone
EP2558432A4 (en) METHOD FOR THE PRODUCTION OF TETRAFLUOROLEFINES
ZA201300776B (en) Improved process for the preparation of febuxostat
PL390042A1 (pl) Sposób wytwarzania kwasu chlebowego
SG11201400939YA (en) Process for the preparation of methoxymelonal
EP2640711A4 (en) IMPROVED PROCESS FOR PREPARING RUFINAMIDE
EP2563768A4 (en) MANUFACTURE OF FEBUXOSTAT
ZA201207397B (en) Process for the preparation of dexlansoprazole
PL388931A1 (pl) Sposób otrzymywania fluorokarbofunkcyjnych silseskwioksanów
IL221184A (en) A process for preparing 1-alkylated tetrazole 5 is produced
EP2596007A4 (en) PROCESS FOR THE PREPARATION OF 17-DEOXY-CORTICOSTEROIDS
ZA201300546B (en) Process for the preparation of 3-haloalkylpyrazoles
PT2593423E (pt) Processo para a preparação de agentes de contraste
PT2603319E (pt) Processo para a preparação de uretanos
PT2390246T (pt) Processo para a preparação de aminaftona
HUP1000018A2 (en) Process for the preparation of distrontium ranelate
PL391551A1 (pl) Sposób otrzymywania bakteriofagów
PT2598504E (pt) Novo processo de fabrico de dimiracetam
IL224304A (en) A process for making dichlorobulben
PL391539A1 (pl) Sposób wytwarzania tworzyw akrylowo-formaldehydowo-mocznikowych
PL390811A1 (pl) Sposób otrzymywania glicydolu